Medical Devices & Combination Products
Healthcare systems worldwide face a range of challenges - from rising rates of chronic diseases and aging populations to a lack of healthcare professionals. These challenges can be addressed in part through innovative therapies and concepts that improve patient empowerment and autonomy. To achieve this, the worlds of medical devices and pharmaceuticals must move closer, creating a regulatory environment supportive of rapid digital innovation and the merging of technologies – starting with better devices for medicines’ application and extending to new smart applications to assist patients, caregivers, and healthcare professionals. Digital innovation has the potential to revolutionize the healthcare industry, from AI-powered medical devices that can diagnose diseases more accurately to telemedicine platforms that enable remote consultations and monitoring. By embracing digital innovation, we can improve patient outcomes, increase efficiency, and reduce costs in the healthcare system.
Who is This Track Designed For?
We welcome interest and involvement from a broad spectrum of individuals and organisations – including but not limited to - authorities, Notified Bodies, patient organisations, and manufacturers of devices and combination products.
Topic Leader
Sabina Hoekstra-van den Bosch
Regulatory Strategy Principal
TÜV SÜD, Netherlands
Thomas Wejs Moller
Director Global Regulatory Affairs - Devices
Novo Nordisk, Denmark